Elanco Animal Health (ELAN) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Elanco Animal Health Incorporated (ELAN) Analyst/Investor Day Transcript
Elanco Animal Health Incorporated (ELAN) Presents at Piper Sandler 37th Annual Healthcare Conference Transcript
| Specialty Retail Industry | Consumer Discretionary Sector | Jeffrey N. Simmons CEO | XFRA Exchange | US28414H1032 ISIN |
| US Country | 9,000 Employees | - Last Dividend | - Last Split | - IPO Date |
Elanco Animal Health Incorporated is an animal health company founded in 1954 with its headquarters in Greenfield, Indiana. Specializing in the innovation, development, manufacturing, and marketing of products for pets and farm animals, Elanco aims to improve the health and productivity of those animals through a comprehensive range of products. The company distributes its offerings globally, catering to third-party distributors, veterinarians, and farm animal producers, which include beef and dairy farmers, as well as those involved in pork, poultry, and aquaculture operations.